Skip to main content
SpringerLink
Log in

Orlistat

A Viewpoint by Priscilla A. Hollander

  • Adis Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hollander PA, Elbein SC, Hirsch IB, et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care 1998 Aug; 21: 1288–94

    Article  PubMed  CAS  Google Scholar 

  2. Bray GA, Pi-Sunyer FX, Hollander P, et al. Effect of orlistat in overweight patients with type 2 diabetes receiving insulin therapy [abstract]. Diabetes 2001 Jun; 50 Suppl. 2: 107

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Baylor University Medical Center, Dallas, Texas, USA

    Priscilla A. Hollander

Authors
  1. Priscilla A. Hollander
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hollander, P.A. Orlistat. Drugs 61, 2120 (2001). https://doi.org/10.2165/00003495-200161140-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200161140-00012

Search

Navigation